MedTrace Logo

Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery

NCT01939028 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2020-08-27

Study results available
· View outcomes & findings →

Summary

This clinical trial studies lymph node mapping in patients with newly diagnosed endometrial cancer undergoing surgery. Lymph node mapping may help in planning surgery to remove endometrial cancer and affected lymph nodes.

Conditions

  • Stage I Endometrial Carcinoma
  • Stage II Endometrial Carcinoma
  • Stage III Endometrial Carcinoma
  • Stage IV Endometrial Carcinoma

Interventions

PROCEDURE

lymph node mapping

Undergo lymph node mapping using isosulfan blue and/or indocyanine green solution

PROCEDURE

sentinel lymph node biopsy

Undergo SLN biopsy

DRUG

isosulfan blue

Undergo lymph node mapping using isosulfan blue and/or indocyanine green solution

DRUG

indocyanine green solution

Undergo lymph node mapping using isosulfan blue and/or indocyanine green solution

PROCEDURE

therapeutic conventional surgery

Undergo hysterectomy, bilateral salpingo-oophorectomy and/or complete pelvic lymphadenectomy

PROCEDURE

lymphadenectomy

Undergo para-aortic lymphadenectomy

Sponsors & Collaborators

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Chad Michener, MD · Case Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01939028 on ClinicalTrials.gov